AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2008
Mar 25, 2008
30786_dirs_2008-03-25_5bc7c187-e854-4d41-be95-642a72feb17d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2002-02-06
Reporting Person: SCHWARTZ NORMAN D (Director, CEO, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2002-02-06 | Incentive Stock Option (right to buy) | $31.77 | A | 7482 | Acquired | 2007-02-06 | Bio-Rad B Common Stock (7482) | Direct |
| 2002-02-06 | Non-Qualified Stock Option (right to buy) | $28.88 | A | 2518 | Acquired | 2012-02-06 | Bio-Rad B Common Stock (2518) | Direct |
Footnotes
F1: The number of shares subject to this stock option grant was incorrectly split between incentive and non-qualified stock options on the Form 4 as originally filed, although the combined total number of shares for the two types of options included in this grant was reported correctly.
F2: The stock option vests over five years at 20% per year beginning one year from the grant date.
F3: The expiration date was incorrectly stated on the Form 4 as originally filed.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Share Issue/Capital Change
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13